Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 6

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 6
---

     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     183,328  
     -  
     -  
     183,328 
  
    Net loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (5,417,315) 
     (5,417,315)
  
    Balance at June 30, 2025 (Successor) 
     1,429  
    $1,287,315  
     -  
    $-  
     60  
    $46,935  
     9,503  
    $7,240,180  
     1,194,802  
    $119  
    $71,311,399  
    $(78,750) 
    $(81,441,099) 
    $(1,633,901)

3

    Convertible
    Preferred Stock  

    Total 

    Series
    A  
    Series
    B  
    Series
    C  
    Series
    D  
    Series A
Common Stock  
    Additional
Paid-in  
    Stock
Subscriptions  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Capital  
    Receivable  
    Deficit  
    Deficit 

    Balance
    at February 14, 2024 (Successor) 
     10,089  
    $8,937,852  
     -  
    $-  
     -  
    $-  
     -  
    $-  
     7,266  
    $      1  
    $53,899,885  
    $(2,000,000) 
    $(63,185,641)